ANI PHARMACEUTICALS INC

By person

16 insiders · 48 transactions

28.7×

Nikhil Lalwani holds 28.7 times base salary in stock. $24.08M of shares against $837.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Nikhil Lalwani last reported holding, valued at $71.00, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lalwani Nikhil

PRESIDENT & CEO

—

$5.05M (3)

−$5.05M

339,089

1.51%

$24.08M

−9.3%

Walsh Patrick D

Director

—

$2.32M (4)

−$2.32M

38,432

0.1709%

$2.73M

−48.6%

CAREY STEPHEN P.

SVP & CFO

—

$1.78M (7) scheduled

−$1.78M

171,843

0.7640%

$12.20M

+6.1%

Mutz Christopher

HEAD OF RARE DISEASE

—

$1.64M (6) scheduled

−$1.64M

91,309

0.4060%

$6.48M

+9.6%

Gassert Chad

SVP - CORP. DEV. & STRATEGY

—

$1.31M (2)

−$1.31M

233,406

1.04%

$16.57M

−3.9%

Davis Krista

SVP, CHIEF HR OFFICER

—

$1.02M (6) scheduled

−$1.02M

51,946

0.2310%

$3.69M

+3.8%

Gutwerg Ori

SVP, GENERICS

—

$621.44K (3)

−$621.44K

75,534

0.3358%

$5.36M

−2.2%

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

—

$453.87K (12) scheduled

−$453.87K

73,924

0.3287%

$5.25M

+30.3%

Rowland Thomas Andrew

SVP, HEAD - ESTABLISHED BRANDS

—

$393.83K (2)

−$393.83K

38,271

0.1702%

$2.72M

+9.6%

HAUGHEY THOMAS

Director

—

$161.76K (1) scheduled

−$161.76K

38,878

0.1729%

$2.76M

−24.5%

TANNENBAUM RENEE P

Director

—

$146.07K (1)

−$146.07K

29,514

0.1312%

$2.10M

+30.5%

Thoma Jeanne

Director

—

$71.53K (1) scheduled

−$71.53K

26,762

0.1190%

$1.90M

−34.1%

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

—

532,976

2.37%

$37.84M

−24.0%

Pera Antonio R

Director

—

27,017

0.1201%

$1.92M

−13.0%

Leonard Matthew J

Director

—

11,221

0.0499%

$796.69K

−6.4%

Gosebruch Henry O

Director

—

6,662

0.0296%

$473.00K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

CAREY STEPHEN P.

2 Jul 2026

SVP & CFO

Sold after exercise

3,313

$86.00

$284.92K

CAREY STEPHEN P.

5 Jun 2026

SVP & CFO

Sold after exercise

3,312

$80.00

$264.96K

CAREY STEPHEN P.

5 Mar 2026

SVP & CFO

Sold after exercise

4,000

$75.56

$302.24K

CAREY STEPHEN P.

5 Mar 2026

SVP & CFO

Sold after exercise

3,312

$75.42

$249.79K

Show all 48 transactions →

By person

Individual transactions

What was left out